McCullough Florist
Abalos Therapeutics is pioneering a novel immunotherapy approach that utilizes an arenavirus-based technology to develop innovative cancer treatments. Their proprietary AdaptInnate method aims to trigger precise immune responses from within tumors, enabling the immune system to effectively target and dismantle cancerous cells.
With a focus on creating systemically administrable drug candidates, Abalos is advancing lead candidate ABX001, which is designed to persist in cancerous and antigen-presenting cells without causing destruction. The company is committed to enhancing treatment options for patients by developing a pipeline of therapeutics tailored for specific cancer indications.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.